The World Health Organization (WHO) Global Status Report on Noncommunicable Diseases 2010 projects that noncommunicable diseases (NCDs) will be responsible for over 44 million deaths during the next decade, representing an increase of about 15% since 2010. Most of these deaths will occur in the WHO ...regions of Africa, South-East Asia and the Eastern Mediterranean. In the African Region alone, NCDs will cause around 3.9 million deaths by 2020.
more
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...line with the strategic objectives of the Global Action Plan. It proposes an incremental approach that countries can adapt to the specific needs, circumstances and available resources of each individual country. Details of actions to be taken will vary according to national contexts
more
The Sphere standards in national humanitarian response discussion paper sets out to understand and describe opportunities for adapting international humanitarian standards to a regional, national or local level in preparing for, or responding to a disaster. The paper, which includes case studies and... recommendations for humanitarian professionals, is available in English, French and Spanish
more
In der Broschüre wird kurz und knapp erläutert, wie die Gesundheitsversorgung von Asylsuchenden in Deutschland erfolgt, wann man einen Behandlungsschein benötigt, was in einem Notfall zu tun ist oder wie Schwangere versorgt werden. Gleichzeitig weist sie auf wichtige Gegebenheiten, wie die Unters...uchung von Männern durch Ärztinnen, die Aufklärung durch den Arzt oder verfügbare Leistungen für Asylbewerber, hin.
Die Broschüre wurde in Deutsch, Englisch und Arabisch veröffentlicht.
more
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...tivities has been largely guided by small and large pharmaceutical companies according to a variety of parameters, such as perceived/unmet medical need, pressure of investors, market size, scientific discovery potential, and availability of specific technologies. Previous PPLs, issued by the Centers for Disease Control and Prevention.
more
A guide for Regional Workshop and Hospital Technicians
Scaling Up Multi-Sectoral Efforts to Establish a Strong Nutrition Foundation for Uganda’s Development